These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29582698)

  • 1. A new category stent with novel polyphosphazene surface modification.
    Mori H; Jinnouchi H; Diljon C; Torii S; Sakamoto A; Kolodgie FD; Virmani R; Finn AV
    Future Cardiol; 2018 May; 14(3):225-235. PubMed ID: 29582698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COBRA PzF™ coronary stent in clinical and preclinical studies: setting the stage for new antithrombotic strategies?
    Cornelissen A; Sakamoto A; Sato Y; Kawakami R; Mori M; Kawai K; Kutyna M; Fernandez R; Ghosh S; Barakat M; Virmani R; Finn A
    Future Cardiol; 2022 Mar; 18(3):207-217. PubMed ID: 34521223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of late in-stent stenosis in a porcine coronary artery model by cobalt chromium stents with a nanocoat of polyphosphazene (Polyzene-F).
    Stampfl U; Sommer CM; Thierjung H; Stampfl S; Lopez-Benitez R; Radeleff B; Berger I; Richter GM
    Cardiovasc Intervent Radiol; 2008; 31(6):1184-92. PubMed ID: 18704573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAPT (Mono Antiplatelet Therapy) as Regular Regimen After COBRA PzF™ NanoCoated Coronary Stent (NCS) Implantation.
    Maillard L; Vochelet F; Peycher P; Ayari A; Barra N; Billé J; Joly P; Silvestri M; Sévilla J; Tavildari A
    Cardiovasc Revasc Med; 2020 Jun; 21(6):785-789. PubMed ID: 31780418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System.
    Cutlip DE; Garratt KN; Novack V; Barakat M; Meraj P; Maillard L; Erglis A; Jauhar R; Popma JJ; Stoler R; Silber S;
    JACC Cardiovasc Interv; 2017 Jan; 10(2):160-167. PubMed ID: 28104210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of the new Polyzene™-F COBRA PzF™ Nanocoated Coronary Stent System (NCS): Addressing an unmet clinical need.
    Styllou P; Silber S
    Cardiovasc Revasc Med; 2016; 17(3):209-11. PubMed ID: 26944851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of a novel polyphosphazene surface modified stent.
    Koppara T; Sakakura K; Pacheco E; Cheng Q; Zhao X; Acampado E; Finn AV; Barakat M; Maillard L; Ren J; Deshpande M; Kolodgie FD; Joner M; Virmani R
    Int J Cardiol; 2016 Nov; 222():217-225. PubMed ID: 27497098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.
    Maillard L; de Labriolle A; Brasselet C; Faurie B; Durel N; de Poli F; Bosle S; Madiot H; Berland J; Belle L
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):45-54. PubMed ID: 32548891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent.
    Maillard L; Tavildari A; Barra N; Billé J; Joly P; Peycher P; Silvestri M; Vochelet F
    Arch Cardiovasc Dis; 2017 Dec; 110(12):682-688. PubMed ID: 29102364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomographic results at six-month follow-up evaluation of the CATANIA coronary stent system with nanothin Polyzene-F surface modification (from the Assessment of The LAtest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial).
    La Manna A; Capodanno D; Cera M; Di Salvo ME; Sacchetta G; Corcos T; Prati F; Tamburino C
    Am J Cardiol; 2009 Jun; 103(11):1551-5. PubMed ID: 19463514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and design.
    Tamburino C; Capodanno D; La Manna A; di Salvo M; Sanfilippo A; Prati F
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):53-8. PubMed ID: 19829136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial.
    Tamburino C; La Manna A; Di Salvo ME; Sacchetta G; Capodanno D; Mehran R; Dangas G; Corcos T; Prati F
    JACC Cardiovasc Interv; 2009 Mar; 2(3):197-204. PubMed ID: 19463426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time Course of Reendothelialization with Polyzene-F Nanocoated Cobra PzF™ Coronary Stent on Rabbit Iliac Arteries.
    Maillard L; Corseaux D; Altié A; Ung A; Courageot J; Barakat M; Teiger E; Van Belle E
    Cardiovasc Revasc Med; 2020 Feb; 21(2):195-199. PubMed ID: 31727585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility, safety, and efficacy of a novel polymeric pimecrolimus-eluting stent: traditional pre-clinical safety end points failed to predict 6-month clinical angiographic results.
    Ormiston JA; Webster MW; Schwartz RS; Gladding P; Stewart JT; Kay IP; Ruygrok PN; Hatrick R
    JACC Cardiovasc Interv; 2009 Oct; 2(10):1017-24. PubMed ID: 19850264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent.
    Meredith IT; Verheye S; Dubois CL; Dens J; Fajadet J; Carrié D; Walsh S; Oldroyd KG; Varenne O; El-Jack S; Moreno R; Joshi AA; Allocco DJ; Dawkins KD
    J Am Coll Cardiol; 2012 Apr; 59(15):1362-70. PubMed ID: 22341736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
    Rittger H; Brachmann J; Sinha AM; Waliszewski M; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Breithardt OA; Schmidt M; Zimmermann S; Lonke S; von Cranach M; Nguyen TV; Daniel WG; Wöhrle J
    J Am Coll Cardiol; 2012 Apr; 59(15):1377-82. PubMed ID: 22386286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.